Pricing

Log inSign up

Visus Therapeutics

0 followers

‌

Visus Therapeutics is a clinical-stage company in pursuit of developing the world’s first presbyopia-correcting eye drop with the potential to last at least eight hours.

Industries

Biotechnology

Headquarters

Seattle, United States

Employees

11-50

Links

Org chart

Ben Bergo
CEO

Ben Bergo

Collapse
Rhett Schiffman
Chief Medical Officer & Head of R&D
Tim Grinstead
COO
David Toll
CFO
Lisa Simpson
VP, Clinical Operations & Compliance
Andy Firpo
VP, Information Technology
Patrick Hughes
VP, Pharmaceutical Development
Esther Cuno
VP, Human Resources
Robert Boxeth
Senior Quality Assurance Specialist
Dell Larned
Associate Director, Project Management
Dixie-Lee Shurland
Project Manager

Teams

+6

Leadership Team

9 members

+5

Clinical Operations Team

8 members

+1

Clinical Operations Team

4 members

+1

Accounting and Finance

4 members

Project Management Team

3 members

Similar companies

Elicio Therapeutics

1 follower

Artiva Biotherapeutics

1 follower

ByHeart

2 followers

Cytokinetics

11 followers

Capricor Therapeutics

1 follower

Neurocrine Biosciences

5 followers

Coherus BioSciences

5 followers

4D Molecular Therapeutics

3 followers

KIA

2 followers

The Cumulus Coffee Company

2 followers

Axsome Therapeutics

2 followers

Explore companies